218 related articles for article (PubMed ID: 30748066)
1. Low endoscopy bleeding risk in patients with congenital bleeding disorders.
Tomaszewski M; Bienz M; Kherad O; Restellini S; Laflèche T; Barkun A; Warner M; Bessissow T
Haemophilia; 2019 Mar; 25(2):289-295. PubMed ID: 30748066
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study.
Davis A; Walsh M; McCarthy P; Brown G; Roberts S; Tran H; Street A; Fong CY; Kemp W
Haemophilia; 2013 Jul; 19(4):583-9. PubMed ID: 23560720
[TBL] [Abstract][Full Text] [Related]
3. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.
Coppola A; Windyga J; Tufano A; Yeung C; Di Minno MN
Cochrane Database Syst Rev; 2015 Feb; (2):CD009961. PubMed ID: 25922858
[TBL] [Abstract][Full Text] [Related]
4. Use of crushed tranexamic acid tablets in water for paediatric patients with bleeding disorders.
Al-Huniti A; Marshall L; Rusk D; Pruthi RK; Rodriguez V; Ferdjallah A; Kuhn A
Haemophilia; 2024 May; 30(3):648-657. PubMed ID: 38507239
[TBL] [Abstract][Full Text] [Related]
5. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders.
Kadir RA; Economides DL; Sabin CA; Pollard D; Lee CA
Haemophilia; 1999 Jan; 5(1):40-8. PubMed ID: 10215946
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial.
Eghbali A; Melikof L; Taherahmadi H; Bagheri B
Haemophilia; 2016 Sep; 22(5):e423-6. PubMed ID: 27478149
[TBL] [Abstract][Full Text] [Related]
7. Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey.
Windyga J; Dolan G; Altisent C; Katsarou O; López Fernández MF; Zülfikar B;
Haemophilia; 2016 Sep; 22(5):739-51. PubMed ID: 27292438
[TBL] [Abstract][Full Text] [Related]
8. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
Napolitano M; Di Minno MN; Batorova A; Dolce A; Giansily-Blaizot M; Ingerslev J; Schved JF; Auerswald G; Kenet G; Karimi M; Shamsi T; Ruiz de Sáez A; Dolatkhah R; Chuansumrit A; Bertrand MA; Mariani G
Haemophilia; 2016 Sep; 22(5):752-9. PubMed ID: 27338009
[TBL] [Abstract][Full Text] [Related]
9. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
Asatiani E; Kessler CM;
Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
[TBL] [Abstract][Full Text] [Related]
10. Preventing perioperative bleeding in patients with inherited bleeding disorders.
Watterson C; Beacher N
Evid Based Dent; 2017 Mar; 18(1):28-29. PubMed ID: 28338025
[TBL] [Abstract][Full Text] [Related]
11. Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran.
Mahmoodi M; Peyvandi F; Afrasiabi A; Ghaffarpasand F; Karimi M
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):396-401. PubMed ID: 21451397
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures.
Shortt J; Dunkley S; Rickard K; Baker R; Street A
Haemophilia; 2007 Mar; 13(2):144-8. PubMed ID: 17286766
[TBL] [Abstract][Full Text] [Related]
13. Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency.
James P; Salomon O; Mikovic D; Peyvandi F
Haemophilia; 2014 May; 20 Suppl 4(0 4):71-5. PubMed ID: 24762279
[TBL] [Abstract][Full Text] [Related]
14. Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitors.
Windyga J; Stefanska-Windyga E; Odnoczko E; Baran B; Czubak G
Haemophilia; 2016 Sep; 22(5):e465-8. PubMed ID: 27457184
[No Abstract] [Full Text] [Related]
15. An investigation of the spectrum of common and rare inherited coagulation disorders in north-eastern Iran.
Mansouritorghabeh H; Manavifar L; Banihashem A; Modaresi A; Shirdel A; Shahroudian M; Shoja-E-Razavi G; Pousti H; Esmaily H
Blood Transfus; 2013 Apr; 11(2):233-40. PubMed ID: 23114518
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience.
Holmström M; Tran HT; Holme PA
Haemophilia; 2012 Jul; 18(4):544-9. PubMed ID: 22348384
[TBL] [Abstract][Full Text] [Related]
17. Obstetrical and gynaecological bleeding: a common presenting symptom.
Kadir RA; Aledort LM
Clin Lab Haematol; 2000 Oct; 22 Suppl 1():12-6; discussion 30-2. PubMed ID: 11251653
[TBL] [Abstract][Full Text] [Related]
18. Elective surgery in patients with inherited bleeding disorders: A retrospective analysis.
Clarke L; Dennington PM; Curnow J
Haemophilia; 2021 Sep; 27(5):744-750. PubMed ID: 34142399
[TBL] [Abstract][Full Text] [Related]
19. Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey.
Stoof SC; van Steenbergen HW; Zwagemaker A; Sanders YV; Cannegieter SC; Duvekot JJ; Leebeek FW; Peters M; Kruip MJ; Eikenboom J
Haemophilia; 2015 Jul; 21(4):505-12. PubMed ID: 25688733
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
Cochrane Database Syst Rev; 2012 Mar; (3):CD005011. PubMed ID: 22419303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
